盐酸沙格雷酯|T4978

Sarpogrelate hydrochloride
135159-51-2

￥169 1mg 起订

￥383 5mg 起订

￥617 10mg 起订

上海更新日期：2026-01-06

TargetMol中国（陶术生物）

VIP13年

联系人：邵小姐

电话：021-021-33632979拨打

手机：15002134094 拨打

邮箱：marketing@targetmol.com

产品详情:

中文名称：: 盐酸沙格雷酯

英文名称：: Sarpogrelate hydrochloride

CAS号：: 135159-51-2

品牌：: TargetMol

产地：: 美国

保存条件：: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

产品类别：: 抑制剂

货号：: T4978

Product Introduction

Bioactivity

名称	Sarpogrelate hydrochloride
描述	Sarpogrelate hydrochloride (MCI-9042) , a selective 5-HT2 antagonist, has been widely used as an anti-platelet agent for the treatment of PAD. Target: 5-HT2 Recepter Sarpogrelate is a drug which acts as an antagonist at the 5HT2A and 5-HT2B receptors. Sarpogrelate hydrochloride was shown to have the same affinity as ritanserin for 5-HT2A receptors, with a Ki value of 8.39 nM. Sarpogrelate hydrochloride lacked prominent 5-HT1-like, 5-HT3, beta, H1, H2 and M3 antagonist activity and weakly blocked alpha 1-adrenoceptors (pKB = 6.30). (S)-M-1 showed weak affinity for 5-HT1-like receptors (pKB = 6.30), alpha 1- (pKB = 6.80) and beta- (pKB = 6.54) adrenoceptors, while (R)-M-1 was a weak antagonist at histamine H1 receptors (pKB = 6.49). After 12 weeks of sarpogrelate administration, FBF and LBF responses during RH showed significant increases from 13.2 +/- 1.7 to 18.1 +/- 2.2 mL/min per 100 mL tissue (P < 0.01) and from 8.2 +/- 0.9 to 14.2 +/- 2.1 mL/min per 100 mL tissue (P < 0.05), respectively. Sarpogrelate hydrochloride -induced augmentation of FBF and LBF responses to RH was maintained at 24 weeks. Long-term oral administration of sarpogrelate improves vascular function in patients with PAD.
存储条件	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
溶解度	DMSO : 245 mg/mL (525.78 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (4.29 mM), Sonication is recommended.
关键字	vascular \| thrombosis \| Serotonin Receptor \| Sarpogrelate Hydrochloride \| Sarpogrelate hydrochloride \| Sarpogrelate \| MCI9042 \| MCI 9042 \| Inhibitor \| inhibit \| 5-hydroxytryptamine Receptor \| 5HTReceptor \| 5-HT2R \| 5-HT2A \| 5-HT2 \| 5-HT Receptor \| 5HT Receptor
相关产品	Cefaclor monohydrate \| Tryptamine hydrochloride \| pCPA methyl ester hydrochloride \| Sevoflurane \| Cloperastine hydrochloride \| Venlafaxine hydrochloride \| Alverine citrate \| Dapoxetine hydrochloride \| Mianserin hydrochloride \| Trazodone hydrochloride \| Clozapine N-Oxide \| 1,8-Cineole
相关库	抑制剂库 \| 抗帕金森病化合物库 \| 抗癌上市药物库 \| 经典已知活性库 \| 已知活性化合物库 \| GPCR靶点分子库 \| 膜蛋白靶向化合物库 \| 神经退行性疾病化合物库 \| 药物功能重定位化合物库 \| 疼痛相关化合物库 \| 抗癌临床化合物库 \| 抗癌药物库

盐酸沙格雷酯|||MCI-9042|TargetMol

上海陶术生物科技有限公司为美国Target Molecule Corp. ( Target Mol ) 在上海建立的全资子公司。我们与美国波士顿、德国慕尼黑的同事一起，为北美、欧洲和亚洲从事药物研发和生物学研究的科学家提供优质的产品和专业的服务。公司下设筛选事业部，化学事业部，生物事业部和新材料部。从虚拟筛选到实体化合物分子供应；从商业化产品销售到个性化定制合成；从对明确靶点的分子筛选到对明确分子的多靶点筛选，从高通量筛选到化学结构优化，我们都可以满足您的科研用品及技术服务的需求。经过在中国市场五年的精心耕耘，我们已成为筛选化合物领域优秀的供应商，为超过五百家学校和各类企业提供了品质卓越的小分子化合物和药物筛

成立日期	(13年)
注册资本	566.2651万人民币
员工人数	100-500人
年营业额	￥ 1亿以上
经营模式	贸易,试剂,定制,服务
主营行业	化学试剂,生物活性小分子